FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1363901000168101: insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 3 mL pen device (medicinal product unit of use)

Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4151851000168115 insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 3 mL pen device (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4151861000168118 insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Is a lixisenatide 10 microgram/0.2 mL injection, 3 mL pen device true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Is a insulin glargine + lixisenatide true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Is a insulin glargine 100 units/mL injection, 3 mL pen device true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has manufactured dose form injection true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has unit of use pen device true Inferred relationship Some 1909835253
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has intended active ingredient insulin glargine true Inferred relationship Some 169543622
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has Australian BoSS insulin glargine true Inferred relationship Some 169543622
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has Australian BoSS lixisenatide true Inferred relationship Some 1909835252
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device has intended active ingredient lixisenatide true Inferred relationship Some 1909835252
Inbound Relationships Type Active Source Characteristic Refinability Group
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices has MPUU True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Inferred relationship Some 1
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device has MPUU True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Inferred relationship Some 1
Soliqua 100/50 injection, 3 mL pen device Is a True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 x 3 mL pen devices has MPUU True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device Inferred relationship Some 1

Reference Sets

List of Medicines for Brand Consideration reference set

Medicinal product unit of use reference set

Back to Start